B2( CPNQ | Linazolamide intermediate B impurity 2 | 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline )

Catalog No. M27605 CAS No. 115687-05-3

B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	140	In Stock
10MG	222	In Stock
25MG	376	In Stock
50MG	536	In Stock
100MG	777	In Stock
500MG	1548	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

B2
Note

Research use only, not for human use.
Brief Description

B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.
Description

B2 promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease.
In Vitro

——
In Vivo

——
Synonyms

CPNQ | Linazolamide intermediate B impurity 2 | 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline
Pathway

Others
Target

Other Targets
Recptor

GABAB
Research Area

——
Indication

——

Chemical Information

CAS Number

115687-05-3
Formula Weight

396.83
Molecular Formula

C20H17ClN4O3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (126.00 mM)
SMILES

[O-][N+](=O)c1ccc(N2CCN(CC2)C(=O)c2ccc(Cl)cc2)c2cccnc12
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Q Gillani, et al. CGP 35348, GABA B receptor antagonist, has a potential to improve neuromuscular coordination and spatial learning in albino mouse following neonatal brain damage. Biomed Res Int.?2014;2014:295215.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks